Zebrafish Model for Functional Screening of Flow-Responsive Genes.

Jovana Serbanovic-Canic1, Amalia de Luca1, Christina Warboys1

  • 1From the Department of Infection, Immunity and Cardiovascular Disease (J.S.-C., L.A.L., S.H., I.G., M.M., S.F., C.S., N.B., J.-P.A., V.R., T.J.A.C., P.C.E.), INSIGNEO Institute for In Silico Medicine (J.S.-C., V.R., T.J.A.C., P.C.E.), and the Bateson Centre (J.S.-C., J.-P.A., T.J.A.C., P.C.E.), University of Sheffield, United Kingdom; and Departments of Cardiovascular Science (A.d.L., C.W., J.C.M., D.O.H.), Imaging (P.F.F., D.F.), Bioengineering (R.K.), and Aeronautics (S.S.) Imperial College London, United Kingdom; and Cancer Institute, Faculty of Medical Sciences (H.W.), University College London, United Kingdom.

Summary

Atherosclerosis research uses zebrafish to screen genes regulating endothelial cell apoptosis under disturbed blood flow. This functional screening identifies potential therapeutic targets for preventing vascular disease.

Related Concept Videos